Colleagues invited to participate in COVID-19 study

Dear colleagues

If you have received the Moderna COVID-19 vaccine, I am emailing to invite you to take part in the COVID-19 DeplOyed VaccinE Cohort Study (DOVE). This is an observational cohort study run by NHS Greater Glasgow and Clyde and Glasgow University to determine the immunogenicity of deployed COVID-19 vaccines against evolving SARS-CoV-2 variants.

The aim of this research is to look at immune response levels (protection against infection) in people who have had at least one dose of any licenced COVID-19 vaccination against different variants of the virus that causes COVID-19 and other related viruses.  

We are currently interested in individuals that have received either one or two doses of the Moderna vaccine more than 14 days ago. We already have sufficient numbers of volunteers who have had the Pfizer and AZ vaccines.

What does it involve?  Attend the Clinical Trials Facility at the QEUH hospital, sign a consent form and agree to the collection of a blood sample (approximately 30mls).

Am I eligible to participate? If you have received a Moderna deployed vaccine never had a positive PCR or positive antibody test and not on any immunosuppressant medication you may be eligible.  We are looking for people who have not previously had COVID-19.

If you would like to receive further information or take part in the study please email: CovidResearch@ggc.scot.nhs.uk, with the subject line COVID-19 DeplOyed VaccinE Cohort Study (DOVE)

To ensure the appropriate information is sent please advise if you have received one or two vaccine doses, which vaccine you have had and your date(s) of vaccination.

Thanks in advance to anyone who might be interested.

Best wishes

Emma

Professor Emma Thomson PhD FRCP

MRC - University of Glasgow Centre for Virus Research


First published: 12 July 2021